ArticleInternational journal of molecular sciences2020

A Novel Selective Sphingosine Kinase 2 Inhibitor, HWG-35D, Ameliorates the Severity of Imiquimod-Induced Psoriasis Model by Blocking Th17 Differentiation of Naïve CD4 T Lymphocytes.

Sun-Hye Shin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.